对话分析
宏观分析
个别股票
Alpha 实验室
实用工具
Menu
我的活动
ZH
登录
ZH
暴涨分析
/
Hans Biomed Corp.
/
2026-05-14
▲ SURGE
Hans Biomed Corp.
+21.3%
042520
KRX
Healthcare
2026-05-14
27,900
收盘价
23,000
前收盘价
+21.30%
涨幅
2.8x
量比
暴涨原因
제공된 뉴스 기사에서 Hans Biomed Corp.(042520)와 관련된 정보를 찾을 수 없습니다.
·
제공된 뉴스 기사에서 Hans Biomed Corp.(042520)와 관련된 정보를 찾을 수 없습니다.
相关新闻
Neumora Therapeutics to Participate in 25th Annual Needham Virtu
Gurufocus
2026-04-06
After scrapping AXN-2510, Instil Bio hunts for new drug deals
Stocktitan
2026-03-27
Harvard Bioscience shares are trading higher after the company reported preliminary Q4 results, issued FY26 outlook and outlined its long-term strategic focus areas. - Harvard Bioscience (NASDAQ:HBIO)
Benzinga
2026-02-10
Fractyl Health sets March 24 call on 2025 results, business updates
Stocktitan
2026-03-17
Neumora lines up April 13 Needham healthcare conference webcast
Stocktitan
2026-04-06
技术分析
信号
MACD看跌
跌破SMA20
关键指标
44.40
RSI (14)
29895.00
SMA 20
21655.12
Bollinger Lower
38134.88
Bollinger Upper
29895.00
Bollinger Mid
-3139.21
MACD
-2979.94
MACD Signal
-159.27
MACD Hist
查看股票详情
返回暴涨股列表
首页
聊天
组合
活动
菜单
Hans Biomed Corp. +21.3% 暴涨分析 (2026-05-14) | Alpha Lenz